Bevacizumab: not as good with more adverse reactions? Response
- PMID: 22452699
- DOI: 10.1111/j.1442-9071.2011.02703.x
Bevacizumab: not as good with more adverse reactions? Response
Comment on
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical